← All peptides
Immune
Longevity & Anti-aging
Preclinical

Thymulin

Also known as: Thymulin

Thymulin is a zinc-dependent thymic nonapeptide hormone that supports T-cell maturation and modulates immune and neuroendocrine signaling. It is studied as an immunoregulatory and anti-inflammatory agent.

Last updated

Mechanism of Action

Thymulin is secreted by thymic epithelial cells and requires bound zinc to become biologically active; the metal ion confers the conformation needed for receptor engagement. It promotes differentiation and functional maturation of T lymphocytes and modulates cytokine release, generally dampening pro-inflammatory mediators such as TNF-alpha and IL-1. Acting on the hypothalamic-pituitary axis, it also participates in bidirectional neuroendocrine-immune crosstalk. Its activity is tightly coupled to circulating zinc availability, which declines with age and immunosenescence.

Half-life
Short, estimated minutes to a few hours in circulation
Administration Routes
subcutaneous
Research Status
Preclinical

Reported Benefits

  • Supports T-lymphocyte maturation and immune function
  • Anti-inflammatory cytokine modulation in animal models
  • Investigated for age-related immune decline
  • Studied for nociceptive and analgesic signaling
  • May help regulate neuroendocrine-immune balance

Potential Side Effects

  • Limited human safety data
  • Potential injection-site irritation
  • Theoretical immune dysregulation with overuse
  • Unknown effects with chronic administration

Common Dosing

For research use only: animal and exploratory protocols have referenced microgram-range subcutaneous dosing; no validated human dosing exists. Not personal medical advice.

The dosing information above is aggregated from research literature and anecdotal community reports for educational purposes only. It is not a recommendation, prescription, or medical advice. Peptides are sold as research chemicals only and are not intended for human use.

Contraindications

  • Autoimmune conditions without specialist oversight
  • Pregnancy and breastfeeding
  • Active immunosuppressive therapy
  • Physiology and therapeutic potential of the thymic peptide thymulin

    2014

    View
  • The thymus-neuroendocrine axis: physiology, molecular biology, and therapeutic potential of the thymic peptide thymulin

    2009

    View
  • Serum thymulin in human zinc deficiency

    1988

    View
  • An open trial of thymulin (FTS-Zn) in rheumatoid arthritis patients: sequential clinical and immunological follow-up

    1987

    View

Zinc binding induces the active conformation of the peptide; without it the molecule is biologically inactive, which links thymulin activity directly to zinc status.

No. It remains a preclinical research compound studied mainly in animal and laboratory models.

PeptideChat is for educational and research purposes only. Nothing on this site constitutes medical advice. Peptides are sold as research chemicals only and are not intended for human use. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. PeptideChat is an independent educational resource — not a pharmacy, compounding, or 503A/503B outsourcing facility — and does not sell products or provide medical advice.